Importantly, high expression of SLC25A1 in lung cancer patients was associated with a poor outcome, particularly after successful surgery (R0-resection), pointing to a potential clinical relevance of SLC25A1 particularly in terms of tumor recurrence. Here, SLC25A1 is linked to neoplasm.